Financhill
Sell
32

AFGVF Quote, Financials, Valuation and Earnings

Last price:
$0.77
Seasonality move :
1.5%
Day range:
$0.77 - $0.77
52-week range:
$0.73 - $1.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.10x
P/B ratio:
0.35x
Volume:
--
Avg. volume:
67
1-year change:
5.55%
Market cap:
$119.2M
Revenue:
$1.2B
EPS (TTM):
-$0.48

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Agfa-Gevaert NV has -- downside to fair value with a price target of -- per share.

AFGVF vs. S&P 500

  • Over the past 5 trading days, Agfa-Gevaert NV has underperformed the S&P 500 by -0.1% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Agfa-Gevaert NV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Agfa-Gevaert NV revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Agfa-Gevaert NV reported revenues of $300.3M.

Earnings Growth

  • Agfa-Gevaert NV earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Agfa-Gevaert NV reported earnings per share of -$0.14.
Enterprise value:
253.2M
EV / Invested capital:
0.46x
Price / LTM sales:
0.10x
EV / EBIT:
4.36x
EV / Revenue:
0.21x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
7.03x
Price / Operating cash flow:
3.31x
Enterprise value / EBITDA:
2.56x
Gross Profit (TTM):
$362.7M
Return On Assets:
-4.84%
Net Income Margin (TTM):
-6.07%
Return On Equity:
-21.03%
Return On Invested Capital:
-13.37%
Operating Margin:
-1.95%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $1.2B $1.2B $1.2B $304.3M $300.3M
Gross Profit $376.5M $381.3M $362.7M $90.1M $80.6M
Operating Income -$203.1M $9.5M $58M -$1.1M -$5.8M
EBITDA -$150M $57.2M $98.9M $11M $4.7M
Diluted EPS -$1.87 -$0.25 -$0.48 -$0.09 -$0.14
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $1.6B $1.3B $833.2M $878.3M $851.9M
Total Assets $2.5B $2.1B $1.4B $1.5B $1.5B
Current Liabilities $684.9M $626M $393.9M $415.2M $421.8M
Total Liabilities $1.7B $1.3B $995.2M $1.1B $1.2B
Total Equity $806.6M $766.1M $448.9M $401.8M $339.6M
Total Debt $89.2M $49M $73.1M $179.7M $191.5M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$72.9M -$7.7M $67.4M $6.6M $40.3M
Cash From Investing -$36.1M -$46.7M -$28.5M -$14.3M -$9.7M
Cash From Financing -$11.6M $63.5M -$26.2M -$2.2M -$43M
Free Cash Flow -$107.2M -$57.6M $36M -$7.7M $29.2M
AFGVF
Sector
Market Cap
$119.2M
$27.9M
Price % of 52-Week High
66.38%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
-3.11%
-1.49%
1-Year Price Total Return
5.55%
-16.66%
Beta (5-Year)
0.046
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $0.77
200-day SMA
Sell
Level $0.96
Bollinger Bands (100)
Sell
Level 0.9 - 1.2
Chaikin Money Flow
Buy
Level 13.7K
20-day SMA
Sell
Level $0.77
Relative Strength Index (RSI14)
Sell
Level 0.52
ADX Line
Sell
Level 99.15
Williams %R
Sell
Level 0
50-day SMA
Sell
Level $1.00
MACD (12, 26)
Sell
Level -0.07
25-day Aroon Oscillator
Sell
Level -16
On Balance Volume
Sell
Level -125.7K

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.0486)
Sell
CA Score (Annual)
Level (-1.3081)
Buy
Beneish M-Score (Annual)
Level (-2.7964)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (1.7558)
Sell
Piotroski F Score (Annual)
Level (3)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Agfa-Gevaert NV engages in the development, manufacture, and distribution of analogue and digital systems for the printing industry, the healthcare sector, and specific industrial applications. It operates through the following segments: HealthCare IT, Radiology Solutions, Digital Print and Chemicals, and Offset Solutions. The HealthCare IT segment focuses on imaging data management. The Radiology Solutions segment provides analog and digital imaging technology. The Digital Print and Chemicals segment supplies sign and display printing companies with inkjet printers with matched inks. The Offset Solutions segment offers commercial, newspaper, and packaging printers, and prepress and printing solutions. The company was founded on June 10, 1964 and is headquartered in Mortsel, Belgium.

Stock Forecast FAQ

In the current month, AFGVF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AFGVF average analyst price target in the past 3 months is --.

  • Where Will Agfa-Gevaert NV Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Agfa-Gevaert NV share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Agfa-Gevaert NV?

    Analysts are divided on their view about Agfa-Gevaert NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Agfa-Gevaert NV is a Sell and believe this share price will rise from its current level to --.

  • What Is Agfa-Gevaert NV's Price Target?

    The price target for Agfa-Gevaert NV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is AFGVF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Agfa-Gevaert NV is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of AFGVF?

    You can purchase shares of Agfa-Gevaert NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Agfa-Gevaert NV shares.

  • What Is The Agfa-Gevaert NV Share Price Today?

    Agfa-Gevaert NV was last trading at $0.77 per share. This represents the most recent stock quote for Agfa-Gevaert NV. Yesterday, Agfa-Gevaert NV closed at $0.77 per share.

  • How To Buy Agfa-Gevaert NV Stock Online?

    In order to purchase Agfa-Gevaert NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 20

Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.

Buy
54
BMRN alert for Dec 20

BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.

Buy
82
RKLB alert for Dec 20

Rocket Lab Corp. [RKLB] is up 17.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock